CIS compliance for Kendall Square, the global biotech epicenter.
HIPAA, HITRUST CSF, FDA 21 CFR Part 11, Massachusetts 201 CMR 17, GDPR, SOC 2, and ISO 27001 compliance automated for the biotech, clinical-research, MIT, and gene-therapy tenants of Kendall Square.
Boston Kendall Square compliance at a glance, for fast retrieval.
Atomic factual claims auditors and search engines can cite verbatim.
- Address
- Kendall Square, Cambridge, MA 02139
- Anchor tenants
- Biogen, Moderna, Vertex, Pfizer Kendall, Sanofi Genzyme, Takeda, Novartis NIBR, MIT, Broad Institute, Whitehead
- Primary sectors
- Biotech / biopharma, gene therapy, clinical research, university research, digital health
- Frameworks
- HIPAA, HITRUST CSF, FDA 21 CFR Part 11, Mass 201 CMR 17, GDPR, SOC 2, ISO 27001
- Data residency
- AWS us-east-1, on-premises Kendall Square
- Air-gapped support
- Yes, including FDA-validated GxP zones
- Deployment timeline
- Under one business day
- Sample customer profiles
- Phase III biotech with global clinical trials, gene-therapy scaleup, MIT lab spinout
Compliance in Kendall Square, Cambridge / Boston.
Kendall Square in Cambridge is the global epicenter of biotechnology research and the densest concentration of biopharma R&D in the world. The square hosts Biogen HQ, Moderna HQ, Vertex Pharmaceuticals, Pfizer Kendall, Sanofi Genzyme, Takeda Cambridge, Novartis Institutes for BioMedical Research (NIBR), and the broader Cambridge biotech-startup ecosystem with hundreds of Series-A through Phase-III biotech operators. MIT (Massachusetts Institute of Technology) and the Broad Institute (a joint MIT-Harvard genomics center) sit at the heart of the cluster, with the Whitehead Institute and the McGovern Institute for Brain Research adjacent. The compliance landscape is the strictest biotech / life-sciences stack in the US: HIPAA + HITRUST for patient and clinical-trial data, FDA 21 CFR Part 11 for GxP-regulated environments, Massachusetts 201 CMR 17 for personal information, GDPR for EU clinical-trial cohorts, plus SOC 2 / ISO 27001 for the digital-health subset.
Frameworks CISGuard maps for Boston Kendall Square.
Each scan generates per-framework reports showing satisfied / partial / not-met status.
| Framework | Scope | Authority |
|---|---|---|
| HIPAA Security Rule → | Patient and research personal health data | US HHS / OCR |
| HITRUST CSF → | Biotech, payer, provider, BAA | HITRUST Alliance |
| FDA 21 CFR Part 11 | Electronic records / signatures in FDA-regulated environments | US Food and Drug Administration |
| Massachusetts 201 CMR 17 | Personal information of MA residents | Massachusetts Office of Consumer Affairs |
| GDPR → | EU clinical-trial cohorts and patient data | EU Commission |
| SOC 2 Type II → | Digital-health and clinical-trial platforms | AICPA |
Sovereignty and residency, solved by architecture.
Kendall Square biotech tenants handle PHI under HIPAA + HITRUST, GxP-regulated data under FDA 21 CFR Part 11, MA personal information under 201 CMR 17, and EU clinical-trial data under GDPR simultaneously. CISGuard's single-tenant deployment satisfies each direction with the data perimeter staying inside Kendall Square or AWS us-east-1, with FDA-validated GxP-zone air-gapped support for the regulated manufacturing and clinical-trial systems.
Three ways to deploy in Boston Kendall Square.
AWS US East (us-east-1, Northern Virginia)
Single-tenant CISGuard inside the customer's AWS Northern Virginia VPC. Closest hyperscaler to Kendall Square.
On-premises Kendall Square
Customer data centre inside Kendall Square or Broad Institute / MIT-adjacent facility. Single-tenant, no SaaS dependency.
Air-gapped (FDA GxP zones)
For FDA-validated GxP environments (LIMS, manufacturing execution, clinical-trial systems). Quarterly signed-media updates.
Boston Kendall Square in practice.
Phase III biotech, Kendall Square
HIPAA + HITRUST CSF + FDA 21 CFR Part 11 + Mass 201 CMR 17 + GDPR evidence automated for the Kendall Square clinical-trial infrastructure of a Phase III biotech. FDA inspection audit-trail review compressed from weeks to days.
Read full case study →Boston Kendall Square questions, answered directly.
How does CISGuard support FDA 21 CFR Part 11 for Kendall Square biotech?
CISGuard's immutable audit trail records every CIS benchmark scan, drift event, and configuration change with timestamps and asset identity. Kendall Square biotech operators use CISGuard for the audit-trail integrity FDA inspectors review during validation of GxP-regulated systems (LIMS, manufacturing execution, clinical-trial systems).
Can CISGuard handle HITRUST CSF certification for Kendall Square biotech?
Yes. CISGuard maps CIS benchmark output to HITRUST CSF control objectives, producing the technical-controls evidence HITRUST assessors expect during i1 (one-year), r2 (two-year), or e1 (single-year basic) certification. Kendall Square biotechs use CISGuard for both pre-assessment readiness and ongoing continuous compliance.
Does CISGuard handle MIT and Broad Institute research-data security?
Yes. MIT and Broad Institute spin-out and research-collaboration programmes carry NIH grant FISMA Moderate, IRB-mandated data security controls, and contractual industry-partner baselines. CISGuard's multi-framework mapping covers all of these from a single CIS benchmark scan, with per-engagement scoped dashboards for the lab-by-lab compliance posture.
Ready to deploy in Boston Kendall Square?
Our compliance engineers have helped organizations across Boston Kendall Square achieve regulatory readiness in as little as one business day.